🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

Epigenomics AG (ECXk)

Frankfurt
Currency in EUR
1.40
+0.40(+40.00%)
Closed
ECXk Scorecard
Full Analysis
Impressive gross profit margins
Earnings results expected tomorrow
Fair Value
Day's Range
1.201.60
52 wk Range
0.502.65
Bid/Ask
1.00 / 1.40
Prev. Close
1
Open
1.2
Day's Range
1.2-1.6
52 wk Range
0.5-2.65
Volume
332
Average Volume (3m)
986
1-Year Change
-59.35%
Fair Value
Unlock
Fair Value Upside
Unlock
ECXk Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Epigenomics AG Company Profile

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company’s products also include Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. The company was founded in 1998 and is headquartered in Berlin, Germany.

Compare ECXk to Peers and Sector

Metrics to compare
ECXk
Peers
Sector
Relationship
P/E Ratio
0.4x−5.3x−0.6x
PEG Ratio
0.00−0.120.00
Price/Book
−0.1x2.1x2.6x
Price / LTM Sales
8.4x5.6x3.2x
Upside (Analyst Target)
-0.0%47.5%
Fair Value Upside
Unlock7.7%6.7%Unlock

FAQ

What Is the Epigenomics (ECXk) Stock Price Today?

The Epigenomics stock price today is 1.40

What Stock Exchange Does Epigenomics Trade On?

Epigenomics is listed and trades on the Frankfurt stock exchange.

What Is the Stock Symbol for Epigenomics?

The stock symbol for Epigenomics is "ECXk."

What Is the Epigenomics Market Cap?

As of today, Epigenomics market cap is 875.15K.

What is Epigenomics Earnings Per Share?

The Epigenomics EPS is 3.39.

What Is the Next Epigenomics Earnings Date?

Epigenomics will release its next earnings report on 05 Nov 2024.

From a Technical Analysis Perspective, Is ECXk a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.